
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Efficacy and safety of programmed death-1 inhibitors combined with chemotherapy in patients with advanced gastric cancer - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4A2E78AF2005305A2E70059CE561A.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="bmcgast">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369166/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="BMC Gastroenterology">
<meta name="citation_title" content="Efficacy and safety of programmed death-1 inhibitors combined with chemotherapy in patients with advanced gastric cancer">
<meta name="citation_author" content="Xiaofei Cheng">
<meta name="citation_author_institution" content="Department of Oncology, Anqing 116 Hospital, No. 150 Shuangjing Street, Anqing, 246003 China">
<meta name="citation_author" content="Yang Zhang">
<meta name="citation_author_institution" content="Department of Oncology, Anqing 116 Hospital, No. 150 Shuangjing Street, Anqing, 246003 China">
<meta name="citation_author" content="Xingyuan Li">
<meta name="citation_author_institution" content="Department of Oncology, Anqing 116 Hospital, No. 150 Shuangjing Street, Anqing, 246003 China">
<meta name="citation_author" content="Zhenning Xu">
<meta name="citation_author_institution" content="Department of Oncology, Anqing 116 Hospital, No. 150 Shuangjing Street, Anqing, 246003 China">
<meta name="citation_author" content="Yaolin Chen">
<meta name="citation_author_institution" content="Department of Oncology, Anqing 116 Hospital, No. 150 Shuangjing Street, Anqing, 246003 China">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="25">
<meta name="citation_firstpage" content="609">
<meta name="citation_doi" content="10.1186/s12876-025-04207-0">
<meta name="citation_pmid" content="40841930">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369166/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369166/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369166/pdf/12876_2025_Article_4207.pdf">
<meta name="description" content="Programmed death-1 (PD-1) inhibitors combined with chemotherapy show certain clinical benefits in advanced gastric cancer patients, but more evidence is still needed. The present study aimed to investigate the efficacy and safety of PD-1 inhibitors ...">
<meta name="og:title" content="Efficacy and safety of programmed death-1 inhibitors combined with chemotherapy in patients with advanced gastric cancer">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Programmed death-1 (PD-1) inhibitors combined with chemotherapy show certain clinical benefits in advanced gastric cancer patients, but more evidence is still needed. The present study aimed to investigate the efficacy and safety of PD-1 inhibitors ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369166/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12369166">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12876-025-04207-0"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12876_2025_Article_4207.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12369166%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12369166/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12369166/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369166/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-bmcgast.png" alt="BMC Gastroenterology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to BMC Gastroenterology" title="Link to BMC Gastroenterology" shape="default" href="https://bmcgastroenterol.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">BMC Gastroenterol</button></div>. 2025 Aug 21;25:609. doi: <a href="https://doi.org/10.1186/s12876-025-04207-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12876-025-04207-0</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22BMC%20Gastroenterol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22BMC%20Gastroenterol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22BMC%20Gastroenterol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22BMC%20Gastroenterol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Efficacy and safety of programmed death-1 inhibitors combined with chemotherapy in patients with advanced gastric cancer</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cheng%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Xiaofei Cheng</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Xiaofei Cheng</span></h3>
<div class="p">
<sup>1</sup>Department of Oncology, Anqing 116 Hospital, No. 150 Shuangjing Street, Anqing, 246003 China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cheng%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiaofei Cheng</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Yang Zhang</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Yang Zhang</span></h3>
<div class="p">
<sup>1</sup>Department of Oncology, Anqing 116 Hospital, No. 150 Shuangjing Street, Anqing, 246003 China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yang Zhang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Xingyuan Li</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Xingyuan Li</span></h3>
<div class="p">
<sup>1</sup>Department of Oncology, Anqing 116 Hospital, No. 150 Shuangjing Street, Anqing, 246003 China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xingyuan Li</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Zhenning Xu</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Zhenning Xu</span></h3>
<div class="p">
<sup>1</sup>Department of Oncology, Anqing 116 Hospital, No. 150 Shuangjing Street, Anqing, 246003 China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhenning Xu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Yaolin Chen</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Yaolin Chen</span></h3>
<div class="p">
<sup>1</sup>Department of Oncology, Anqing 116 Hospital, No. 150 Shuangjing Street, Anqing, 246003 China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yaolin Chen</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Oncology, Anqing 116 Hospital, No. 150 Shuangjing Street, Anqing, 246003 China</div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 26; Accepted 2025 Jul 29; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12369166  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40841930/" class="usa-link">40841930</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Objective</h3>
<p id="Par1">Programmed death-1 (PD-1) inhibitors combined with chemotherapy show certain clinical benefits in advanced gastric cancer patients, but more evidence is still needed. The present study aimed to investigate the efficacy and safety of PD-1 inhibitors combined with chemotherapy in these patients.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">Forty-three patients with advanced gastric cancer receiving PD-1 inhibitors (including camrelizumab, sintilimab, and tislelizumab, 200 mg every 3 weeks) combined with chemotherapy were retrospectively enrolled. Data on treatment response, progression-free survival (PFS), and adverse reactions were collected.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">There were 1 (2.3%), 9 (20.9%), 32 (74.4%), and 1 (2.3%) patient who achieved complete response, partial response, stable disease, and progressive disease, respectively. The objective response rate and disease control rate were 23.3% and 97.7%. The 1- and 2-year cumulative PFS rates were 63.3% and 19.8%. The median PFS (95% confidence interval) was 13.5 (10.7–16.3) months. Higher Eastern Cooperative Oncology Group performance status score (per score) [hazard ratio (HR) = 5.404, <em>P</em> = 0.047] and higher maximum diameter of the lesion (per cm) (HR = 1.860, <em>P</em> = 0.048) independently predicted shorter PFS. The adverse reactions included hemoglobin decreased (76.7%; grade 3: 16.3%), white blood cells decreased (74.4%; grade 3: 7.0%), blood platelet decreased (25.6%; grade 3: 2.3%), white blood cells increased (9.3%; grade 3: none), and reactive cutaneous capillary endothelial proliferation (23.3%; grade 3: 2.3%).</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion</h3>
<p id="Par4">PD-1 inhibitors combined with chemotherapy may be an optional regimen for patients with advanced gastric cancer. However, the retrospective design and small sample size may limit the generalizability and robustness of our findings.</p></section><section id="sec5"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s12876-025-04207-0.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Programmed death-1 inhibitors combined with chemotherapy, Advanced gastric cancer, Treatment response, Progression-free survival, Adverse reactions</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par5">Gastric cancer is a highly aggressive and heterogeneous malignant tumor that seriously threatens human health [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. The prognosis of patients with advanced gastric cancer is very poor, with a median overall survival (OS) of only 10.0-15.7 months [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. Chemotherapy is the cornerstone for the treatment of advanced gastric cancer, but the efficacy of chemotherapy alone is unsatisfactory [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>, <a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. Notably, immunotherapy activates host immune system to eliminate tumor cells, which has led to some progression in the treatment of patients with advanced gastric cancer [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>, <a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>].</p>
<p id="Par6">Programmed death-1 (PD-1) inhibitors, which play a key role in cancer immunotherapy, reactivate T-cell function to suppress tumor growth and immune escape [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>–<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. Previous studies have shown the favorable efficacy and manageable toxicity of PD-1 inhibitors combined with chemotherapy in patients with advanced gastric cancer [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>–<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. For example, the randomized, controlled ATTRACTION-4 trial revealed that nivolumab combined with chemotherapy improved progression-free survival (PFS) compared with placebo combined with chemotherapy in patients with advanced gastric cancer [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. The KEYNOTE-859 study revealed that, compared to placebo plus chemotherapy, pembrolizumab combined with chemotherapy increased OS with tolerable toxicity in patients with advanced gastric cancer [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. Moreover, some previous real-world studies also showed that patients with advanced gastric cancer could benefit from PD-1 inhibitors combined with chemotherapy [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>, <a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. However, more studies are needed to provide additional clinical evidence.</p>
<p id="Par7">Therefore, the purpose of this study was to investigate the treatment response, survival outcome, and adverse reactions of patients with advanced gastric cancer who received PD-1 inhibitors combined with chemotherapy.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Patients</h3>
<p id="Par8">This retrospective, observational study included 43 patients with advanced gastric cancer who received PD-1 inhibitors combined with chemotherapy.</p>
<p id="Par9">Patients were consecutively enrolled from May 2021 to March 2024. The inclusion criteria were as follows: (1) patients who were diagnosed with gastric cancer via a pathological method; (2) patients who had advanced disease: with tumor-node-metastasis (TNM) stage III/IV; (3) patients who were aged more than 18 years; (4) patients who received PD-1 inhibitors; and (5) patients whose treatment response data was available. Patients who were HER2 positive (+ + or +++) measured by immunohistochemistry (IHC) + fluorescence in situ hybridization ratio (FISH), had Eastern Cooperative Oncology Group performance status (ECOG PS) scores greater than 2, or other primary malignancies were excluded. This retrospective study was approved by the Institutional Review Board of Anqing 116 Hospital (Approval no. 2023-HYNL-037). All procedures were followed in accordance with the Declaration of Helsinki under the Ethics approval. Each participant signed the informed consent form.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Treatment</h3>
<p id="Par10">Patients in the present study received PD-1 inhibitors combined with chemotherapy. PD-1 inhibitors, including camrelizumab, sintilimab, and tislelizumab, were used in this study. Camrelizumab, sintilimab, and tislelizumab were administrated at 200 mg every 3 weeks until disease progression or intolerance. Chemotherapy drugs, including fluorouracil, tegafur, S-1, capecitabine, raltitrexed, cisplatin, nedaplatin, oxaliplatin, docetaxel, albumin-bound paclitaxel, paclitaxel, and irinotecan, were used in this study. This study did not interfere with the treatment of patients. Treatment selection was based on physician judgment and patient preference, and the physician judgment was in accordance with the Chinese Society of Clinical Oncology (CSCO) guidelines [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>].</p></section><section id="Sec5"><h3 class="pmc_sec_title">Data collection</h3>
<p id="Par11">The data extracted from the electronic medical record database of Anqing 116 Hospital was collected from January 2024 to May 2024. Clinical features, including age, gender, smoke, hypertension, history of gastrectomy, history of radiotherapy, ECOG PS score, histological type, TNM stage, differentiation, and status of metastasis, were retrieved. In addition, baseline laboratory indexes, including blood tumor markers, blood routine examinations, and blood biochemical indexes, were also collected.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Observed indicators</h3>
<p id="Par12">Clinical response information was gathered and evaluated via CT or MRI every 2 months after treatment as per the iRECIST guideline [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. Patients initially assessed as PD were designated unconfirmed progressive disease, and they were confirmed as either pseudoprogression or confirmed progressive disease in the next assessment (Patients continued to receive treatment during the period). In our study, there were 3 patients with pseudoprogression, and these patients continued to receive the treatment and follow-up. No patient continued treatment when diagnosed as confirmed progressive disease. The median number of actual scans per patient was 3, and 22 (51.5%) patients deviated from the schedule (2 months ± 1 week). The median follow-up time of the patients was 5.4 months. The observed indicators included the objective response rate (ORR), disease control rate (DCR), and cumulative PFS rate. Adverse reactions were collected and evaluated via the Common Terminology Criteria for Adverse Events (v.5.0), which was accessible at <a href="https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_5x7.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_5x7.pdf</a>).</p></section><section id="Sec7"><h3 class="pmc_sec_title">Statistics</h3>
<p id="Par13">Statistical analysis was carried out by SPSS v.29.0 (IBM, USA). Continuous variables were presented as median with interquartile range (IQR). The counting variables were presented as numbers with percentages. Patients lost to follow-up (<em>n</em> = 21) were censored at their last known progression-free date in the Kaplan-Meier analysis. Given high loss to follow-up, a sensitivity analysis was performed by worst-case scenarios analysis. The Kaplan-Meier method was performed for estimating accumulating PFS rates, and the Log-rank test was applied to compare them. The multivariate Cox regression model was performed to assess the associations of clinical features with PFS. A post hoc statistical power analysis was conducted using One-Sample Log-rank Test module of PASS software (version 15.0.5, NCSS, LLC). A <em>P</em> value &lt; 0.05 indicated significance.</p></section></section><section id="Sec8"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec9"><h3 class="pmc_sec_title">Clinical features and laboratory indexes</h3>
<p id="Par14">The median (IQR) age of the 43 patients was 71.0 (61.0–77.0) years. Among these patients, 7 (16.3%) were females and 36 (83.7%) were males. In terms of TNM stage, 21 (48.8%) patients were in TNM stage III and 22 (51.2%) were in TNM stage IV. There were 32 (74.4%) patients with metastasis. More specific information is shown in Table <a href="#Tab1" class="usa-link">1</a>.</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Clinical characteristics of patients with advanced gastric cancer</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Characteristics</th>
<th align="left" colspan="1" rowspan="1">Patients (<em>N</em> = 43)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Age (years), median (IQR)</td>
<td align="left" colspan="1" rowspan="1">71.0 (61.0–77.0)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Gender, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Female</td>
<td align="left" colspan="1" rowspan="1">7 (16.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Male</td>
<td align="left" colspan="1" rowspan="1">36 (83.7)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Smoke, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Never</td>
<td align="left" colspan="1" rowspan="1">25 (58.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Former or current</td>
<td align="left" colspan="1" rowspan="1">18 (41.9)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Hypertension, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">29 (67.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">14 (32.6)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">History of gastrectomy, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">24 (55.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">19 (44.2)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">History of radiotherapy, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">33 (76.7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">10 (23.3)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">ECOG PS score, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 0</td>
<td align="left" colspan="1" rowspan="1">2 (4.7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 1</td>
<td align="left" colspan="1" rowspan="1">35 (81.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 2</td>
<td align="left" colspan="1" rowspan="1">6 (14.0)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Histological type, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Adenocarcinoma</td>
<td align="left" colspan="1" rowspan="1">39 (90.7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Squamous carcinoma, signet ring cell carcinoma, or unknown</td>
<td align="left" colspan="1" rowspan="1">4 (9.3)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">TNM stage, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> III</td>
<td align="left" colspan="1" rowspan="1">21 (48.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> IV</td>
<td align="left" colspan="1" rowspan="1">22 (51.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Maximum diameter of the lesion (cm), median (IQR)</td>
<td align="left" colspan="1" rowspan="1">2.3 (1.2–3.2)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Differentiation, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Well-to-moderately or moderately</td>
<td align="left" colspan="1" rowspan="1">4 (9.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Moderately-to-poorly or poorly</td>
<td align="left" colspan="1" rowspan="1">22 (51.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Undifferentiated or unable to assess</td>
<td align="left" colspan="1" rowspan="1">17 (39.5)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Metastasis, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">11 (25.6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">32 (74.4)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Lymphatic metastasis, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">29 (67.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">14 (32.6)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Peritoneal metastasis, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">35 (81.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">8 (18.6)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Liver metastasis, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">31 (72.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">12 (27.9)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Bone metastasis, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">40 (93.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">3 (7.0)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p18">
<p>The continuous variables were presented as median with interquartile range (IQR). The counting variables were presented as numbers with percentages</p>
<p><em>IQR</em> Interquartile range, <em>ECOG PS</em> Eastern cooperative oncology group performance status, <em>TNM</em> Tumor-node-metastasis</p>
</div></div></section><p id="Par16">The laboratory indexes of patients with advanced gastric cancer were collected. Regarding blood tumor markers, the median (IQR) values of carcinoembryonic antigen, carbohydrate antigen (CA) 125, CA 199, and alpha-fetoprotein were 4.3 (1.8–24.8) ng/mL, 23.0 (12.5–44.9) U/mL, 13.4 (5.0-62.9) U/mL, and 2.8 (2.0-5.2) ng/mL, respectively. Other detailed laboratory indexes, including blood routine examinations and blood biochemical indexes, are listed in Table <a href="#Tab2" class="usa-link">2</a>.</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Laboratory indexes of patients with advanced gastric cancer</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Items</th>
<th align="left" colspan="1" rowspan="1">Patients (<em>N</em> = 43)</th>
</tr></thead>
<tbody>
<tr><td align="left" colspan="2" rowspan="1">Blood tumor markers</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> CEA (ng/mL), median (IQR)</td>
<td align="left" colspan="1" rowspan="1">4.3 (1.8–24.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> CA 125 (U/mL), median (IQR)</td>
<td align="left" colspan="1" rowspan="1">23.0 (12.5–44.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> CA 199 (U/mL), median (IQR)</td>
<td align="left" colspan="1" rowspan="1">13.4 (5.0-62.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> AFP (ng/mL), median (IQR)</td>
<td align="left" colspan="1" rowspan="1">2.8 (2.0-5.2)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Blood routine examinations</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> WBC (10^9/L), median (IQR)</td>
<td align="left" colspan="1" rowspan="1">4.9 (3.7–6.7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> RBC (10^12/L), median (IQR)</td>
<td align="left" colspan="1" rowspan="1">3.6 (3.3-4.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Hb (g/L), median (IQR)</td>
<td align="left" colspan="1" rowspan="1">104.0 (96.0-124.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> PLT (10^9/L), median (IQR)</td>
<td align="left" colspan="1" rowspan="1">208.5 (152.8-272.8)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Blood biochemical indexes</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ALP (IU/L), median (IQR)</td>
<td align="left" colspan="1" rowspan="1">79.0 (64.5-105.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ALT (IU/L), median (IQR)</td>
<td align="left" colspan="1" rowspan="1">14.0 (11.0-25.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> AST (IU/L), median (IQR)</td>
<td align="left" colspan="1" rowspan="1">23.5 (20.0-28.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ALB (g/L), median (IQR)</td>
<td align="left" colspan="1" rowspan="1">39.4 (35.3–42.6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Cr (µmol/L), median (IQR)</td>
<td align="left" colspan="1" rowspan="1">69.5 (59.5–82.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> UA (µmol/L), median (IQR)</td>
<td align="left" colspan="1" rowspan="1">276.0 (229.3-325.5)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p23">
<p>The laboratory indexes were presented as median with interquartile range (IQR). The counting variables were presented as numbers with percentages</p>
<p><em>IQR</em> Interquartile range, <em>CEA</em> Carcinoembryonic antigen, <em>CA</em> Carbohydrate antigen, <em>AFP</em> Alpha-fetoprotein, <em>WBC</em> White blood cell count, <em>RBC</em> Red blood cell count, <em>Hb</em> hemoglobin, <em>PLT</em> Platelet count, <em>ALP</em> Alkaline phosphatase, <em>ALT</em> Alanine aminotransferase, <em>AST</em> Aspartate aminotransferase, <em>ALB</em> Albumin, <em>Cr</em> Creatinine, <em>UA</em> Uric acid</p>
</div></div></section></section><section id="Sec10"><h3 class="pmc_sec_title">Treatment response</h3>
<p id="Par18">One (2.3%) patient achieved complete response (CR). Meanwhile, there were 9 (20.9%) patients who had partial response (PR), 32 (74.4%) patients who had stable disease (SD), and 1 (2.3%) patient who achieved progressive disease (PD). Patients achieved an ORR of 23.3% and a DCR of 97.7%, respectively (Table <a href="#Tab3" class="usa-link">3</a>).</p>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Clinical response</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Items</th>
<th align="left" colspan="1" rowspan="1">Patients (<em>N</em> = 43)</th>
</tr></thead>
<tbody>
<tr><td align="left" colspan="2" rowspan="1">Best response, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> CR</td>
<td align="left" colspan="1" rowspan="1">1 (2.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> PR</td>
<td align="left" colspan="1" rowspan="1">9 (20.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> SD</td>
<td align="left" colspan="1" rowspan="1">32 (74.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> PD</td>
<td align="left" colspan="1" rowspan="1">1 (2.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ORR, n (%)</td>
<td align="left" colspan="1" rowspan="1">10 (23.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> DCR, n (%)</td>
<td align="left" colspan="1" rowspan="1">42 (97.7)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p28">
<p>The clinical responses were presented as numbers with percentages</p>
<p><em>CR</em> Complete response, <em>PR</em> Partial response, <em>SD</em> Stable disease, <em>PD</em> Progressive disease, <em>ORR</em> Objective response rate, <em>DCR</em> Disease control rate</p>
</div></div></section></section><section id="Sec11"><h3 class="pmc_sec_title">PFS and related factors</h3>
<p id="Par20">The 1-year and 2-year cumulative PFS rates were 63.3% and 19.8%, respectively. The median (95% confidence interval (CI)) PFS was 13.5 (10.7–16.3) months (Fig. <a href="#Fig1" class="usa-link">1</a>). Lower ECOG PS score (<em>P</em> = 0.004) and adenocarcinoma status (<em>P</em> = 0.043) were related to prolonged PFS (Fig. <a href="#Fig2" class="usa-link">2</a>A-B). However, there was no association of TNM stage (<em>P</em> = 0.253), the degree of differentiation (<em>P</em> = 0.639), or metastasis (<em>P</em> = 0.719) with PFS (Fig. <a href="#Fig2" class="usa-link">2</a>C-E). Moreover, the multivariate analysis revealed that higher ECOG PS score (per score) [hazard ratio (HR) = 5.404, <em>P</em> = 0.047] and maximum diameter of the lesion (per cm) (HR = 1.860, <em>P</em> = 0.048) were independently associated with reduced PFS (Table <a href="#Tab4" class="usa-link">4</a>).</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369166_12876_2025_4207_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a1/12369166/b637a3c1a2ed/12876_2025_4207_Fig1_HTML.jpg" loading="lazy" id="d33e814" height="538" width="744" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Accumulating PFS rates of patients with advanced gastric cancer who received PD-1 inhibitors combined with chemotherapy</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369166_12876_2025_4207_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a1/12369166/55c9ca9590cd/12876_2025_4207_Fig2_HTML.jpg" loading="lazy" id="d33e840" height="380" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Association of clinical features with PFS in patients with advanced gastric cancer who received PD-1 inhibitors combined with chemotherapy. The association of ECOG PS score (<strong>A</strong>), histological type (<strong>B</strong>), TNM stage (<strong>C</strong>), differentiation (<strong>D</strong>), and metastasis (<strong>E</strong>) with PFS in patients with advanced gastric cancer who received PD-1 inhibitors combined with chemotherapy</p></figcaption></figure><section class="tw xbox font-sm" id="Tab4"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>The multivariate Cox regression analysis on PFS</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Characteristics</th>
<th align="left" rowspan="2" colspan="1">
<em>P</em> value</th>
<th align="left" rowspan="2" colspan="1">HR</th>
<th align="left" colspan="2" rowspan="1">95% CI</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Lower</th>
<th align="left" colspan="1" rowspan="1">Upper</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Hypertension (yes vs. no)</td>
<td align="left" colspan="1" rowspan="1">0.747</td>
<td align="left" colspan="1" rowspan="1">1.396</td>
<td align="left" colspan="1" rowspan="1">0.184</td>
<td align="left" colspan="1" rowspan="1">10.559</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">History of gastrectomy (yes vs. no)</td>
<td align="left" colspan="1" rowspan="1">0.431</td>
<td align="left" colspan="1" rowspan="1">0.482</td>
<td align="left" colspan="1" rowspan="1">0.079</td>
<td align="left" colspan="1" rowspan="1">2.955</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">History of radiotherapy (yes vs. no)</td>
<td align="left" colspan="1" rowspan="1">0.062</td>
<td align="left" colspan="1" rowspan="1">0.085</td>
<td align="left" colspan="1" rowspan="1">0.006</td>
<td align="left" colspan="1" rowspan="1">1.135</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ECOG PS score (per score)</td>
<td align="left" colspan="1" rowspan="1">0.047</td>
<td align="left" colspan="1" rowspan="1">5.404</td>
<td align="left" colspan="1" rowspan="1">1.024</td>
<td align="left" colspan="1" rowspan="1">28.522</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Histological type (squamous carcinoma, signet ring cell carcinoma, or unknown vs. adenocarcinoma)</td>
<td align="left" colspan="1" rowspan="1">0.945</td>
<td align="left" colspan="1" rowspan="1">1.354</td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
<td align="left" colspan="1" rowspan="1">7033.195</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Maximum diameter of the lesion (per cm)</td>
<td align="left" colspan="1" rowspan="1">0.048</td>
<td align="left" colspan="1" rowspan="1">1.860</td>
<td align="left" colspan="1" rowspan="1">1.005</td>
<td align="left" colspan="1" rowspan="1">3.444</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Metastasis (yes vs. no)</td>
<td align="left" colspan="1" rowspan="1">0.486</td>
<td align="left" colspan="1" rowspan="1">0.385</td>
<td align="left" colspan="1" rowspan="1">0.026</td>
<td align="left" colspan="1" rowspan="1">5.663</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Treatment line (second line vs. first line)</td>
<td align="left" colspan="1" rowspan="1">0.415</td>
<td align="left" colspan="1" rowspan="1">2.461</td>
<td align="left" colspan="1" rowspan="1">0.282</td>
<td align="left" colspan="1" rowspan="1">21.492</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">Chemotherapy regimens</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Platinum (reference)</td>
<td align="left" colspan="1" rowspan="1">(-)</td>
<td align="left" colspan="1" rowspan="1">1.000</td>
<td align="left" colspan="1" rowspan="1">(-)</td>
<td align="left" colspan="1" rowspan="1">(-)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Taxanes vs. reference</td>
<td align="left" colspan="1" rowspan="1">0.824</td>
<td align="left" colspan="1" rowspan="1">2.626</td>
<td align="left" colspan="1" rowspan="1">0.001</td>
<td align="left" colspan="1" rowspan="1">13017.647</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Platinum + Taxanes vs. reference</td>
<td align="left" colspan="1" rowspan="1">0.281</td>
<td align="left" colspan="1" rowspan="1">3.838</td>
<td align="left" colspan="1" rowspan="1">0.334</td>
<td align="left" colspan="1" rowspan="1">44.148</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Others vs. reference</td>
<td align="left" colspan="1" rowspan="1">0.297</td>
<td align="left" colspan="1" rowspan="1">3.674</td>
<td align="left" colspan="1" rowspan="1">0.318</td>
<td align="left" colspan="1" rowspan="1">42.381</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p37">
<p>The multivariate Cox regression analyses was performed by enter method</p>
<p><em>PFS</em> Progression-free survival, <em>HR</em> Hazard ratio, <em>CI</em> Confidence interval, <em>ECOG PS</em> Eastern Cooperative Oncology Group performance status</p>
</div></div></section></section><section id="Sec12"><h3 class="pmc_sec_title">Subgroup analyses for PFS</h3>
<p id="Par24">The treatment information (Supplementary Table 1) and lost-to-follow-up information (Supplementary Table 2) of patients are exhibited. Subgroup analyses revealed that PFS did not vary among patients receiving different PD-1 inhibitors (<em>P</em> = 0.754) or different chemotherapy regimens (<em>P</em> = 0.573) (Supplementary Fig. 1A-B). Moreover, PFS was not affected by the reasons of lost follow-up, either (<em>P</em> = 0.491) (Supplementary Fig. 2).</p></section><section id="Sec13"><h3 class="pmc_sec_title">Sensitivity analysis</h3>
<p id="Par25">Sensitivity analysis by worst-case scenarios analysis disclosed that the median (95% CI) PFS was 7.3 (3.2–11.5) months in patients with advanced gastric cancer who received PD-1 inhibitors combined with chemotherapy (Supplementary Fig. 3).</p></section><section id="Sec14"><h3 class="pmc_sec_title">Adverse reactions</h3>
<p id="Par26">There were 33 (76.7%) patients with hemoglobin decreased, including 7 (16.3%) patients of grade III. A total of 32 (74.4%) patients experienced white blood cells decreased, of which 3 (7.0%) were grade III. Blood platelet decreased occurred in 11 (25.6%) patients, and there was 1 (2.3%) patient of grade III. Four (9.3%) patients experienced white blood cells increased, and none of them was grade III. Moreover, there were 10 (23.3%) patients with reactive cutaneous capillary endothelial proliferation (RCCEP), of whom 1 (2.3%) patient was grade III (Table <a href="#Tab5" class="usa-link">5</a>).</p>
<section class="tw xbox font-sm" id="Tab5"><h4 class="obj_head">Table 5.</h4>
<div class="caption p"><p>Adverse reactions</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Reactions, <em>n</em> (%)</th>
<th align="left" colspan="1" rowspan="1">Any</th>
<th align="left" colspan="1" rowspan="1">Grade I</th>
<th align="left" colspan="1" rowspan="1">Grade II</th>
<th align="left" colspan="1" rowspan="1">Grade III</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Hemoglobin decreased</td>
<td align="center" colspan="1" rowspan="1">33 (76.7)</td>
<td align="center" colspan="1" rowspan="1">12 (27.9)</td>
<td align="center" colspan="1" rowspan="1">14 (32.6)</td>
<td align="center" colspan="1" rowspan="1">7 (16.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">White blood cells decreased</td>
<td align="center" colspan="1" rowspan="1">32 (74.4)</td>
<td align="center" colspan="1" rowspan="1">11 (25.6)</td>
<td align="center" colspan="1" rowspan="1">18 (41.9)</td>
<td align="center" colspan="1" rowspan="1">3 (7.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Blood platelet decreased</td>
<td align="center" colspan="1" rowspan="1">11 (25.6)</td>
<td align="center" colspan="1" rowspan="1">8 (18.6)</td>
<td align="center" colspan="1" rowspan="1">2 (4.7)</td>
<td align="center" colspan="1" rowspan="1">1 (2.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">White blood cells increased</td>
<td align="center" colspan="1" rowspan="1">4 (9.3)</td>
<td align="center" colspan="1" rowspan="1">3 (7.0)</td>
<td align="center" colspan="1" rowspan="1">1 (2.3)</td>
<td align="center" colspan="1" rowspan="1">0 (0.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">RCCEP</td>
<td align="center" colspan="1" rowspan="1">10 (23.3)</td>
<td align="center" colspan="1" rowspan="1">8 (18.6)</td>
<td align="center" colspan="1" rowspan="1">1 (2.3)</td>
<td align="center" colspan="1" rowspan="1">1 (2.3)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p44">
<p>The adverse reactions were presented as numbers with percentages</p>
<p><em>RCCEP</em> Reactive cutaneous capillary endothelial proliferation</p>
</div></div></section></section></section><section id="Sec15"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par28">A prior study showed that the ORR was 66.0% and the DCR was 91.0% in patients with advanced gastric cancer who were treated with nivolumab plus chemotherapy [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. Another study found that patients with advanced gastric cancer receiving camrelizumab combined with chemotherapy achieved an ORR and a DCR of 62.2% and 82.2%, respectively [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. In our study, the ORR and DCR of patients with advanced gastric cancer who received PD-1 inhibitors combined with chemotherapy were 23.3% and 97.7%, respectively. The ORR was lower and the DCR was similar in our study versus those in previous studies [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. This might be attributed to the following reasons: (1) The patients included in our study had a mean (IQR) age of 71.0 (61.0–77.0) years. These patients might not be able to receive a complete treatment cycle; therefore, the ORR of our study was relatively low. (2) A large proportion of patients (74.4%) had metastasis, which might influence the results. (3) It was hypothesized that the programmed cell death ligand 1 status and microsatellite instability status of patients might also lead to the low ORR; however, our study did not collect this information. Notably, in our study, the DCR of 97.7% was driven by a high rate of SD (74.4%). Meanwhile, the cumulative PFS rates showed that a major proportion of patients had no disease progression over 12 months. This finding indicated that SD might have a durable effect rather than a transient effect. Moreover, for elderly patients with advanced cancers, a stable disease condition might be a more practical treatment goal than tumor shrinkage [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. However, the above results of our study might not be sufficiently generalizable and robust due to the retrospective design and small sample size, which required further verification.</p>
<p id="Par29">A study suggested that the median PFS was 10.03 months in patients with untreated, HER2-negative, advanced gastric cancer who underwent camrelizumab plus chemotherapy [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. In another study, the median PFS was 10.45 months in patients with advanced gastric cancer who received nivolumab plus chemotherapy [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. The median PFS of our study was 13.5 months in patients with advanced gastric cancer who received PD-1 inhibitors combined with chemotherapy. The PFS of our study was higher than the results from the above studies [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>], which might be because: Although ORR was only 23.3% in our study, the vast majority of patients had SD (74.4%), which indicated that these patients’ conditions were under control, thus prolonging PFS. Our study also found that lower ECOG PS score and adenocarcinoma were linked with prolonged PFS in these patients. The possible reasons would be as follows: (1) Patients with lower ECOG PS scores might have an increased ability to tolerate treatment, leading to better prognoses [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>, <a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. (2) In our study, there were 39 patients with adenocarcinoma and 4 patients with squamous carcinoma, signet ring cell carcinoma, or unknown histological types. These four patients might represent outliers due to the small subgroup size, thus influencing the results. However, it was only a speculation and required further verification. Moreover, our study conducted multivariate analysis. The results showed that higher ECOG PS score and maximum diameter of the lesion were independently associated with shorter PFS, while histological type was not an independent factor linked with PFS. The independent association of maximum diameter of the lesion with PFS might because: Higher maximum diameter of the lesion represented increased tumor burden, thus reflecting disease progression [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. Similarly, it was necessary to emphasize that all results still required further verification due to the retrospective design and the small sample size of our study.</p>
<p id="Par30">Although PD-1 inhibitors combined with chemotherapy have exhibited some clinical benefits for advanced gastric cancer, their related adverse reactions should not be ignored [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. A previous study showed that the most frequent adverse reactions were peripheral sensory neuropathy, decreased appetite, nausea, platelet count decreased, and neutrophil count decreased in patients with advanced gastric cancer receiving pembrolizumab plus S-1 and oxaliplatin [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. Another study disclosed that the most common adverse reactions included nausea, platelet count decreased, white blood cell count decreased, and neutrophil count decreased in patients with advanced gastric cancer who received nivolumab plus chemotherapy [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. The adverse reactions in our study were partly similar to those of previous studies [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. In our study, the adverse reactions were hemoglobin decreased (76.7%), white blood cells decreased (74.4%), blood platelet decreased (25.6%) and white blood cells increased (9.3%). The grade 3 adverse reactions included hemoglobin decreased (16.3%), white blood cells decreased (7.0%), and white blood cells increased (2.3%). Regarding immune-related adverse reactions, 10 (23.3%) patients experienced RCCEP, and 1 (2.3%) patient was grade III. Moreover, there was no new adverse reaction. These findings revealed that the safety profile of PD-1 inhibitors combined with chemotherapy was acceptable in patients with advanced gastric cancer. Nevertheless, more prospective studies with large sample sizes were needed for further verification.</p>
<p id="Par31">Notably, in our study, the proportion of patients lost to follow-up was high. In detail, a total of 21 patients suspended medication, abandoned treatment, or could not be contacted during the follow-up period. The detailed explanations were as follows: (1) The drugs used in our study were expensive and not covered by medical insurance at the time, which placed a heavy financial burden on patients’ families. Meanwhile, since these patients (<em>n</em> = 9) were already in the advanced stage and most of them were older, their families chose to give up treatment eventually. (2) Due to the coronavirus disease 2019 (COVID-19) pandemic, some participants (<em>n</em> = 7) were not followed up at that time and could not be contacted later.</p>
<p id="Par32">It was necessary to clarify, in our study, the ORR was relatively low (23.3%), but the median PFS was relatively favorable (13.5 months), which could be explained by the following reason: Although the ORR was relatively low, the SD was high (74.4%), indicating that most patients had no disease progression.</p>
<p id="Par33">Our study had several limitations: (1) The sample size of our study was small (<em>N</em> = 43), which limited the statistical power of our findings. For example, the CIs around the efficacy estimates (ORR and PFS) might be wide, and the results might not be generalizable to a broader population of patients with advanced gastric cancer. A post hoc statistical power analysis based on a previous study was performed [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>], revealing that our study achieved a statistical power of 81.4%. However, a larger sample size was still required for further verification in future studies. (2) The results of subgroup analyses might be underpowered and potentially unreliable due to the small number in the subgroups. (3) Our study was a real-world study that provided evidence on the feasibility of PD-1 inhibitors combined with chemotherapy for advanced gastric cancer. However, the lack of a control group made it difficult to definitively attribute the therapeutic efficacy entirely to the addition of PD-1 inhibitors. Although our study compared our results to some historical data from previous studies, the differences between studies (such as patient selection, baseline characteristics, treatment eras, and study methodologies) caused the comparative results to be indirect and biased. Thus, future studies should include a control group to compare the efficacy and safety of PD-1 inhibitors combined with chemotherapy versus chemotherapy alone in patients with advanced gastric cancer. (4) Our study was a retrospective study, which was inherently prone to selection bias, information bias, and some confounding variables that might not have been adequately controlled for. Meanwhile, the lack of randomization and a pre-defined protocol might impact the validity of the results. Thus, more prospective studies were needed for further verification. (5) Due to the constraint of a retrospective study design, some critical biomarker data for gastric cancer (such as programmed death ligand-1status or microsatellite instability status) were not retrieved. The absence of these critical biomarkers limited our study’s ability to identify patient subgroups most likely to benefit from treatment and reduced the comparability of our findings with those of other studies. (6) Moreover, due to some reasons (such as COVID-19 and patients giving up treatment), the rate of patients who were lost to follow-up was high, potentially causing overestimation of median PFS. (7) Given the limitation of retrospective design, some information on treatment delays, dose reductions, or therapy discontinuations related to adverse reactions could not be retrieved. This might limit the clinical utility of the safety findings and reduce confidence in the safety profile assessment of the treatment combination. Moreover, the collection and grading of adverse reactions might be subject to variability and underreporting compared to a prospective study with systematic monitoring, which created uncertainty about the true safety profile and led to underestimation of treatment-related toxicities. (8) The median follow-up time of our study was relatively shorter (5.4 months), and a longer follow-up time was required to fully assess the long-term efficacy of PD-1 inhibitors combined with chemotherapy in patients with advanced gastric cancer. (9) Our study was conducted at a single institution in China. Thus, the findings might not be directly generalizable to other ethnic populations or healthcare settings with differences in patient characteristics, treatment practices, or access to care. (10) The lack of treatment standardization might also be a limitation that affected our results. Overall, the results, particularly the ORR and PFS results, needed to be interpreted with caution due to these limitations.</p></section><section id="Sec16"><h2 class="pmc_sec_title">Conclusions</h2>
<p id="Par34">In conclusion, PD-1 inhibitors combined with chemotherapy may be an alternative choice for patients with advanced gastric cancer. However, the efficacy and safety of the PD-1 inhibitors combined with chemotherapy regimen may be overestimated due to the constraints of a retrospective study design. Thus, this treatment modality still requires confirmation in more clinical trials.</p></section><section id="Sec17"><h2 class="pmc_sec_title">Supplementary Information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12369166/bin/12876_2025_4207_MOESM1_ESM.tif" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1.</a><sup> (387KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12369166/bin/12876_2025_4207_MOESM2_ESM.tif" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 2.</a><sup> (574.8KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM3"><div class="media p"><div class="caption">
<a href="/articles/instance/12369166/bin/12876_2025_4207_MOESM3_ESM.tif" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 3.</a><sup> (582.1KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM4"><div class="media p"><div class="caption">
<a href="/articles/instance/12369166/bin/12876_2025_4207_MOESM4_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 4.</a><sup> (17.5KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM5"><div class="media p"><div class="caption">
<a href="/articles/instance/12369166/bin/12876_2025_4207_MOESM5_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 5.</a><sup> (17.2KB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Not applicable.</p></section><section id="notes1"><h2 class="pmc_sec_title">Authors’ contributions</h2>
<p>Xiaofei Cheng contributed to the conception of the study. Yang Zhang, Xingyuan Li, Zhenning Xu and Yaolin Chen contributed to the data acquisition. Xiaofei Cheng, Yang Zhang and Xingyuan Li contributed to the analysis of data. Xiaofei Cheng, Yang Zhang, Xingyuan Li, Zhenning Xu and Yaolin Chen wrote and revised the manuscript. All authors read and approved the final manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>No funding was received.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par35">This study was approved by the Ethics Review Board of the Department of Oncology, Anqing 116 Hospital. All procedures were followed in accordance with the Declaration of Helsinki under the Ethics approval. Each participant signed the informed consent.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par36">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par37">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol. 2022;28(12):1187–203.
</cite> [<a href="https://doi.org/10.3748/wjg.v28.i12.1187" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8968487/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35431510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ilic%20M,%20Ilic%20I.%20Epidemiology%20of%20stomach%20cancer.%20World%20J%20Gastroenterol.%202022;28(12):1187%E2%80%93203." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Yang WJ, Zhao HP, Yu Y, Wang JH, Guo L, Liu JY, et al. Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J Gastroenterol. 2023;29(16):2452–68.
</cite> [<a href="https://doi.org/10.3748/wjg.v29.i16.2452" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10167900/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37179585/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20WJ,%20Zhao%20HP,%20Yu%20Y,%20Wang%20JH,%20Guo%20L,%20Liu%20JY,%20et%20al.%20Updates%20on%20global%20epidemiology,%20risk%20and%20prognostic%20factors%20of%20gastric%20cancer.%20World%20J%20Gastroenterol.%202023;29(16):2452%E2%80%9368." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Digklia A, Wagner AD. Advanced gastric cancer: current treatment landscape and future perspectives. World J Gastroenterol. 2016;22(8):2403–14.
</cite> [<a href="https://doi.org/10.3748/wjg.v22.i8.2403" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4768187/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26937129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Digklia%20A,%20Wagner%20AD.%20Advanced%20gastric%20cancer:%20current%20treatment%20landscape%20and%20future%20perspectives.%20World%20J%20Gastroenterol.%202016;22(8):2403%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Ogata T, Narita Y, Oze I, Kumanishi R, Nakazawa T, Matsubara Y, et al. Chronological improvement of survival in patients with advanced gastric cancer over 15 years. Therapeutic Adv Med Oncol. 2024;16:17588359241229428.</cite> [<a href="https://doi.org/10.1177/17588359241229428" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10858657/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38344409/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ogata%20T,%20Narita%20Y,%20Oze%20I,%20Kumanishi%20R,%20Nakazawa%20T,%20Matsubara%20Y,%20et%20al.%20Chronological%20improvement%20of%20survival%20in%20patients%20with%20advanced%20gastric%20cancer%20over%2015%20years.%20Therapeutic%20Adv%20Med%20Oncol.%202024;16:17588359241229428." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Wagner AD, Syn NL, Moehler M, Grothe W, Yong WP, Tai BC, et al. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 2017;8(8):Cd004064.
</cite> [<a href="https://doi.org/10.1002/14651858.CD004064.pub4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6483552/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28850174/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wagner%20AD,%20Syn%20NL,%20Moehler%20M,%20Grothe%20W,%20Yong%20WP,%20Tai%20BC,%20et%20al.%20Chemotherapy%20for%20advanced%20gastric%20cancer.%20Cochrane%20Database%20Syst%20Rev.%202017;8(8):Cd004064." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Ajani JA, D’Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(2):167–92.
</cite> [<a href="https://doi.org/10.6004/jnccn.2022.0008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35130500/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ajani%20JA,%20D%E2%80%99Amico%20TA,%20Bentrem%20DJ,%20Chao%20J,%20Cooke%20D,%20Corvera%20C,%20et%20al.%20Gastric%20cancer,%20version%202.2022,%20NCCN%20clinical%20practice%20guidelines%20in%20oncology.%20J%20Natl%20Compr%20Canc%20Netw.%202022;20(2):167%E2%80%9392." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16(1):57.
</cite> [<a href="https://doi.org/10.1186/s13045-023-01451-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10225110/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37245017/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guan%20WL,%20He%20Y,%20Xu%20RH.%20Gastric%20cancer%20treatment:%20recent%20progress%20and%20future%20perspectives.%20J%20Hematol%20Oncol.%202023;16(1):57." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Jin X, Liu Z, Yang D, Yin K, Chang X. Recent progress and future perspectives of immunotherapy in advanced gastric cancer. Front Immunol. 2022;13:948647.
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.948647" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9284215/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35844558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jin%20X,%20Liu%20Z,%20Yang%20D,%20Yin%20K,%20Chang%20X.%20Recent%20progress%20and%20future%20perspectives%20of%20immunotherapy%20in%20advanced%20gastric%20cancer.%20Front%20Immunol.%202022;13:948647." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Tang Q, Chen Y, Li X, Long S, Shi Y, Yu Y, et al. The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers. Front Immunol. 2022;13:964442.
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.964442" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9513184/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36177034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tang%20Q,%20Chen%20Y,%20Li%20X,%20Long%20S,%20Shi%20Y,%20Yu%20Y,%20et%20al.%20The%20role%20of%20PD-1/PD-L1%20and%20application%20of%20immune-checkpoint%20inhibitors%20in%20human%20cancers.%20Front%20Immunol.%202022;13:964442." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Liu X, Zhao A, Xiao S, Li H, Li M, Guo W, et al. PD-1: A critical player and target for immune normalization. Immunology. 2024;172(2):181–97.
</cite> [<a href="https://doi.org/10.1111/imm.13755" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38269617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20X,%20Zhao%20A,%20Xiao%20S,%20Li%20H,%20Li%20M,%20Guo%20W,%20et%20al.%20PD-1:%20A%20critical%20player%20and%20target%20for%20immune%20normalization.%20Immunology.%202024;172(2):181%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Shiravand Y, Khodadadi F, Kashani SMA, Hosseini-Fard SR, Hosseini S, Sadeghirad H, et al. Immune checkpoint inhibitors in cancer therapy. Curr Oncol. 2022;29(5):3044–60.
</cite> [<a href="https://doi.org/10.3390/curroncol29050247" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9139602/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35621637/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shiravand%20Y,%20Khodadadi%20F,%20Kashani%20SMA,%20Hosseini-Fard%20SR,%20Hosseini%20S,%20Sadeghirad%20H,%20et%20al.%20Immune%20checkpoint%20inhibitors%20in%20cancer%20therapy.%20Curr%20Oncol.%202022;29(5):3044%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Chen RY, Zhu Y, Shen YY, Xu QY, Tang HY, Cui NX, et al. The role of PD-1 signaling in health and immune-related diseases. Front Immunol. 2023;14:1163633.
</cite> [<a href="https://doi.org/10.3389/fimmu.2023.1163633" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10228652/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37261359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20RY,%20Zhu%20Y,%20Shen%20YY,%20Xu%20QY,%20Tang%20HY,%20Cui%20NX,%20et%20al.%20The%20role%20of%20PD-1%20signaling%20in%20health%20and%20immune-related%20diseases.%20Front%20Immunol.%202023;14:1163633." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Kang YK, Chen LT, Ryu MH, Oh DY, Oh SC, Chung HC, et al. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2022;23(2):234–47.
</cite> [<a href="https://doi.org/10.1016/S1470-2045(21)00692-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35030335/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kang%20YK,%20Chen%20LT,%20Ryu%20MH,%20Oh%20DY,%20Oh%20SC,%20Chung%20HC,%20et%20al.%20Nivolumab%20plus%20chemotherapy%20versus%20placebo%20plus%20chemotherapy%20in%20patients%20with%20HER2-negative,%20untreated,%20unresectable%20advanced%20or%20recurrent%20gastric%20or%20gastro-oesophageal%20junction%20cancer%20(ATTRACTION-4):%20a%20randomised,%20multicentre,%20double-blind,%20placebo-controlled,%20phase%203%20trial.%20Lancet%20Oncol.%202022;23(2):234%E2%80%9347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Rha SY, Oh DY, Yañez P, Bai Y, Ryu MH, Lee J, et al. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol. 2023;24(11):1181–95.
</cite> [<a href="https://doi.org/10.1016/S1470-2045(23)00515-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37875143/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rha%20SY,%20Oh%20DY,%20Ya%C3%B1ez%20P,%20Bai%20Y,%20Ryu%20MH,%20Lee%20J,%20et%20al.%20Pembrolizumab%20plus%20chemotherapy%20versus%20placebo%20plus%20chemotherapy%20for%20HER2-negative%20advanced%20gastric%20cancer%20(KEYNOTE-859):%20a%20multicentre,%20randomised,%20double-blind,%20phase%203%20trial.%20Lancet%20Oncol.%202023;24(11):1181%E2%80%9395." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398(10294):27–40.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(21)00797-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8436782/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34102137/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Janjigian%20YY,%20Shitara%20K,%20Moehler%20M,%20Garrido%20M,%20Salman%20P,%20Shen%20L,%20et%20al.%20First-line%20nivolumab%20plus%20chemotherapy%20versus%20chemotherapy%20alone%20for%20advanced%20gastric,%20gastro-oesophageal%20junction,%20and%20oesophageal%20adenocarcinoma%20(CheckMate%20649):%20a%20randomised,%20open-label,%20phase%203%20trial.%20Lancet.%202021;398(10294):27%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Yamaguchi K, Minashi K, Sakai D, Nishina T, Omuro Y, Tsuda M, et al. Phase IIb study of pembrolizumab combined with S-1 + oxaliplatin or S-1 + cisplatin as first-line chemotherapy for gastric cancer. Cancer Sci. 2022;113(8):2814–27.
</cite> [<a href="https://doi.org/10.1111/cas.15462" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9357620/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35701865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yamaguchi%20K,%20Minashi%20K,%20Sakai%20D,%20Nishina%20T,%20Omuro%20Y,%20Tsuda%20M,%20et%20al.%20Phase%20IIb%20study%20of%20pembrolizumab%20combined%20with%20S-1%E2%80%89+%E2%80%89oxaliplatin%20or%20S-1%E2%80%89+%E2%80%89cisplatin%20as%20first-line%20chemotherapy%20for%20gastric%20cancer.%20Cancer%20Sci.%202022;113(8):2814%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Xu M, Meng X, Lu Y, Wang F. Efficacy and safety of camrelizumab in combination with trastuzumab and chemotherapy as the first-line treatment for patients with HER2-positive advanced gastric cancer. J Gastrointest Oncol. 2022;13(2):548–58.
</cite> [<a href="https://doi.org/10.21037/jgo-21-897" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9086057/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35557572/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20M,%20Meng%20X,%20Lu%20Y,%20Wang%20F.%20Efficacy%20and%20safety%20of%20camrelizumab%20in%20combination%20with%20trastuzumab%20and%20chemotherapy%20as%20the%20first-line%20treatment%20for%20patients%20with%20HER2-positive%20advanced%20gastric%20cancer.%20J%20Gastrointest%20Oncol.%202022;13(2):548%E2%80%9358." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Wang Y, Zhao J, Yu H, Wang J, Zhang N, Cao B. Efficacy and safety of sintilimab-based regimens against advanced gastric and gastroesophageal junction adenocarcinoma. J Cancer Res Ther. 2021;17(5):1234–40.
</cite> [<a href="https://doi.org/10.4103/jcrt.jcrt_856_21" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34850772/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Zhao%20J,%20Yu%20H,%20Wang%20J,%20Zhang%20N,%20Cao%20B.%20Efficacy%20and%20safety%20of%20sintilimab-based%20regimens%20against%20advanced%20gastric%20and%20gastroesophageal%20junction%20adenocarcinoma.%20J%20Cancer%20Res%20Ther.%202021;17(5):1234%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Wang FH, Zhang XT, Li YF, Tang L, Qu XJ, Ying JE, et al. The Chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun. 2021;41(8):747–95.</cite> [<a href="https://doi.org/10.1002/cac2.12193" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8360643/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34197702/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20FH,%20Zhang%20XT,%20Li%20YF,%20Tang%20L,%20Qu%20XJ,%20Ying%20JE,%20et%20al.%20The%20Chinese%20society%20of%20clinical%20oncology%20(CSCO):%20clinical%20guidelines%20for%20the%20diagnosis%20and%20treatment%20of%20gastric%20cancer,%202021.%20Cancer%20Commun.%202021;41(8):747%E2%80%9395." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Wang FH, Zhang XT, Tang L, Wu Q, Cai MY, Li YF, et al. The Chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer Commun. 2024;44(1):127–72.</cite> [<a href="https://doi.org/10.1002/cac2.12516" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10794017/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38160327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20FH,%20Zhang%20XT,%20Tang%20L,%20Wu%20Q,%20Cai%20MY,%20Li%20YF,%20et%20al.%20The%20Chinese%20society%20of%20clinical%20oncology%20(CSCO):%20clinical%20guidelines%20for%20the%20diagnosis%20and%20treatment%20of%20gastric%20cancer,%202023.%20Cancer%20Commun.%202024;44(1):127%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Seymour L, Bogaerts J, Perrone A, Ford R, Schwartz LH, Mandrekar S, et al. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol. 2017;18(3):e143–52.
</cite> [<a href="https://doi.org/10.1016/S1470-2045(17)30074-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5648544/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28271869/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Seymour%20L,%20Bogaerts%20J,%20Perrone%20A,%20Ford%20R,%20Schwartz%20LH,%20Mandrekar%20S,%20et%20al.%20iRECIST:%20guidelines%20for%20response%20criteria%20for%20use%20in%20trials%20testing%20immunotherapeutics.%20Lancet%20Oncol.%202017;18(3):e143%E2%80%9352." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Liu T, Bai Y, Lin X, Li W, Wang J, Zhang X, et al. First-line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: checkmate 649 Chinese subgroup analysis. Int J Cancer. 2023;152(4):749–60.
</cite> [<a href="https://doi.org/10.1002/ijc.34296" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10092493/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36121651/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20T,%20Bai%20Y,%20Lin%20X,%20Li%20W,%20Wang%20J,%20Zhang%20X,%20et%20al.%20First-line%20nivolumab%20plus%20chemotherapy%20vs%20chemotherapy%20in%20patients%20with%20advanced%20gastric,%20gastroesophageal%20junction%20and%20esophageal%20adenocarcinoma:%20checkmate%20649%20Chinese%20subgroup%20analysis.%20Int%20J%20Cancer.%202023;152(4):749%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Huang X, He D, Lai L, Chen J, Zhang Y, Mao H. Evaluation of clinical efficacy, adverse reactions, and safety of PD-1 inhibitors combined with chemotherapy when treating advanced gastric cancer. BMC Gastroenterol. 2023;23(1):374.
</cite> [<a href="https://doi.org/10.1186/s12876-023-03011-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10619224/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37915064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20X,%20He%20D,%20Lai%20L,%20Chen%20J,%20Zhang%20Y,%20Mao%20H.%20Evaluation%20of%20clinical%20efficacy,%20adverse%20reactions,%20and%20safety%20of%20PD-1%20inhibitors%20combined%20with%20chemotherapy%20when%20treating%20advanced%20gastric%20cancer.%20BMC%20Gastroenterol.%202023;23(1):374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Stegmann ME, Brandenbarg D, Reyners AKL, van Geffen WH, Hiltermann TJN, Berendsen AJ. Treatment goals and changes over time in older patients with non-curable cancer. Support Care Cancer. 2021;29(7):3849–56.
</cite> [<a href="https://doi.org/10.1007/s00520-020-05945-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8163677/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33354736/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Stegmann%20ME,%20Brandenbarg%20D,%20Reyners%20AKL,%20van%20Geffen%20WH,%20Hiltermann%20TJN,%20Berendsen%20AJ.%20Treatment%20goals%20and%20changes%20over%20time%20in%20older%20patients%20with%20non-curable%20cancer.%20Support%20Care%20Cancer.%202021;29(7):3849%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Xiang J, Gong W, Sun P, Wang X, Liu A. Efficacy and safety of camrelizumab plus chemotherapy versus chemotherapy alone in patients with untreated, HER2-negative, unresectable locally advanced, or metastatic gastric cancer or gastroesophageal junction cancer: a retrospective comparative cohort study. J Gastrointest Oncol. 2022;13(6):2874–84.
</cite> [<a href="https://doi.org/10.21037/jgo-22-1229" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9830341/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36636085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xiang%20J,%20Gong%20W,%20Sun%20P,%20Wang%20X,%20Liu%20A.%20Efficacy%20and%20safety%20of%20camrelizumab%20plus%20chemotherapy%20versus%20chemotherapy%20alone%20in%20patients%20with%20untreated,%20HER2-negative,%20unresectable%20locally%20advanced,%20or%20metastatic%20gastric%20cancer%20or%20gastroesophageal%20junction%20cancer:%20a%20retrospective%20comparative%20cohort%20study.%20J%20Gastrointest%20Oncol.%202022;13(6):2874%E2%80%9384." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Chen Z, He Y, Ding C, Chen J, Gu Y, Xiao M, et al. Safety and efficacy analysis of PD-1 inhibitors in combination with gemcitabine plus Nab-Paclitaxel for advanced pancreatic cancer: A Real-World, Single-Center study. OncoTargets Therapy. 2023;16:923–35.
</cite> [<a href="https://doi.org/10.2147/OTT.S427942" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10642393/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37965584/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20Z,%20He%20Y,%20Ding%20C,%20Chen%20J,%20Gu%20Y,%20Xiao%20M,%20et%20al.%20Safety%20and%20efficacy%20analysis%20of%20PD-1%20inhibitors%20in%20combination%20with%20gemcitabine%20plus%20Nab-Paclitaxel%20for%20advanced%20pancreatic%20cancer:%20A%20Real-World,%20Single-Center%20study.%20OncoTargets%20Therapy.%202023;16:923%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Noori M, Mahjoubfar A, Azizi S, Fayyaz F, Rezaei N. Immune checkpoint inhibitors plus chemotherapy versus chemotherapy alone as first-line therapy for advanced gastric and esophageal cancers: a systematic review and meta-analysis. Int Immunopharmacol. 2022;113(Pt A):109317.
</cite> [<a href="https://doi.org/10.1016/j.intimp.2022.109317" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36252494/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Noori%20M,%20Mahjoubfar%20A,%20Azizi%20S,%20Fayyaz%20F,%20Rezaei%20N.%20Immune%20checkpoint%20inhibitors%20plus%20chemotherapy%20versus%20chemotherapy%20alone%20as%20first-line%20therapy%20for%20advanced%20gastric%20and%20esophageal%20cancers:%20a%20systematic%20review%20and%20meta-analysis.%20Int%20Immunopharmacol.%202022;113(Pt%20A):109317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12369166/bin/12876_2025_4207_MOESM1_ESM.tif" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1.</a><sup> (387KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12369166/bin/12876_2025_4207_MOESM2_ESM.tif" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 2.</a><sup> (574.8KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12369166/bin/12876_2025_4207_MOESM3_ESM.tif" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 3.</a><sup> (582.1KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12369166/bin/12876_2025_4207_MOESM4_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 4.</a><sup> (17.5KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12369166/bin/12876_2025_4207_MOESM5_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 5.</a><sup> (17.2KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from BMC Gastroenterology are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12876-025-04207-0"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12876_2025_Article_4207.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12369166/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12369166/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12369166%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369166/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12369166/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12369166/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40841930/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12369166/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40841930/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12369166/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12369166/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="WxMCxqguVG6pJYaVpyMnr0PADF54JKRQkRbsr1oEDfjOq3Q3lMHArtSu0Zy01aMI">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
